Surprisingly, overexpression of HuR in ER-breast cancer leads to an increase in TSP1 and a decrease in VEGF expression, resulting in reduced tumor angiogenesis, so the exact mechanism of the antiangiogenic effect against HuR is not fully understood but may involve an interaction between HuR and microRNAs (113). Here, ELAVL1 is linked to breast carcinoma.